Drug regulator okays limited use of Itolizumab for Covid-19 patients



India’s drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on Covid-19 patients with moderate to severe acute respiratory distress, officials said.


Considering the unmet medical needs to treat Covid-19, Drugs Controller General of India Dr V G Somani approved monoclonal antibody injection Itolizumab for restricted emergency use for the treatment of ‘cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to Covid-19, they said on Friday.



“The approval was given after its clinical trials on Covid-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medicine experts from AIIMS, among others, for treatment of cytokine release syndrome,” an official told PTI.


ALSO READ: Coronavirus LIVE: India cases at 822603; Over 220000 global cases in a day


“It is already an approved drug of Biocon for treating psoriasis for last many years,” the official said.


Written informed consent of each patient is required before the use of this drug, he said.



Source link

Latest

Angels’ Wantz, Mariners’ Winker suspended following bench-clearing brawl

Major League Baseball handed out suspensions to 12 members...

Sri Lanka suspends fuel sales for two weeks as economic crisis worsens

Cash-strapped Sri Lanka has announced a two-week halt to...

Whoopi Goldberg Sends Blistering Warning To Clarence Thomas On His Marriage Rights

Whoopi Goldberg warned Supreme Court Justice Clarence Thomas about...

EXCLUSIVE: Varun Dhawan wants to do a film with Arjun Kapoor; has requested Anees Bazmee to do a film with #Varjun : Bollywood News...

With Jugjugg Jeeyo that hit the theatres recently, we can see that Varun Dhawan is all in form to entertain...

Allowing Corbevax as Booster for Those Vaccinated with Covishield, Covaxin Likely to Be Considered by NTAGI

The Centre has given approval for Biological E's Corbevax to be administered to the 12-14 years age group across the country. (File pic)India's first...